Literature DB >> 17264090

Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis.

F Bartoli1, C Angotti, C Fatini, M L Conforti, S Guiducci, J Blagojevic, D Melchiorre, G Fiori, S Generini, N Damjanov, S Rednic, A Pignone, S Castellani, R Abbate, M Matucci Cerinic.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is characterized by microvascular and macrovascular alterations. The D allele of the ACE I/D polymorphism is known to be associated with an increased incidence of atherosclerosis and has been recently proposed as associated with increased risk of SSc. This study evaluates the relationship between intima-media thickness (IMT), ankle-brachial pressure measurements (ABPI) and ACE I/D polymorphism in SSc patients.
METHODS: According to the presence of ACE D allele (analysed by PCR), 53 SSc patients (47 females and 6 males; median age was 60.4 +/- 10.68 yrs; range 40-75 yrs) were divided in carriers of the D allele (DD + ID) (n = 46) and carriers of the I allele (II) (n = 7). In these patients, IMT and ABPI [calculated as the posterior tibial artery pressure (mmHg) divided by the brachial pressure] were obtained. Forty-three healthy controls (40 women and 13 men; median age 56.3 +/- 10.23; range 40-70 yrs) of the same ethnicity were recruited.
RESULTS: SSc patients had IMT significantly higher than controls (0.85 +/- 0.03 vs 0. 68 +/- 0.01; P < 0.03). No significant differences (P > 0.3) in ABPI values between patients (1.018 +/- 0.10) and controls (1.091 +/- 0.11) were found. SSc patients with ACE DD and ID genotype showed an IMT significantly greater (0.89 +/- 0.03) than those carrying the II genotype (0.61 +/- 0.01) (P < 0.04). ABPI was not different among ACE gene genotypes.
CONCLUSION: Our findings confirm an increased prevalence of macrovascular disease in SSc patients and show that IMT is greater in patients carrying the ACE DD and ID genotype in comparison with II homozygotes. This suggests that, in SSc, the presence of ACE D allele may predispose to an involvement of the macrovascular system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264090     DOI: 10.1093/rheumatology/kel433

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

1.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

Review 2.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

Review 3.  Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Karen Au; Manjit K Singh; Vijay Bodukam; Sangmee Bae; Paul Maranian; Rikke Ogawa; Brennan Spiegel; Maureen McMahon; Bevra Hahn; Dinesh Khanna
Journal:  Arthritis Rheum       Date:  2011-07

4.  Systemic sclerosis is associated with lower limb vascular stiffness and microvascular impairment: results from a prospective study.

Authors:  Charles Cassius; Vannina Seta; Jean-Benoit Monfort; Nathalie Abdoucheli Baudot; Sébastien Rivière; Arsène Mekinian; Camille Frances; Annick Barbaud; Patricia Senet
Journal:  Clin Rheumatol       Date:  2021-03-06       Impact factor: 2.980

5.  Serum salusin-α levels in systemic lupus erythematosus and systemic sclerosis.

Authors:  Süleyman Serdar Koca; Metin Özgen; Bahar Işık; Mustafa Necati Dağlı; Bilal Üstündağ; Ahmet Işık
Journal:  Eur J Rheumatol       Date:  2014-03-01

Review 6.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

Review 7.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

8.  Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis.

Authors:  Jadwiga Skretkowicz; Malgorzata Baranska; Mariola Rychlik-Sych
Journal:  Eur J Clin Pharmacol       Date:  2009-05-15       Impact factor: 2.953

Review 9.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 10.  Cardiovascular disease in systemic sclerosis--an emerging association?

Authors:  Gene-Siew Ngian; Joanne Sahhar; Ian P Wicks; Sharon Van Doornum
Journal:  Arthritis Res Ther       Date:  2011-08-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.